Clinical Observation for TCM Combined Rehabilitation Therapy for Relieving Type 2 Diabetes Mellitus Based on the Thought of Regulating and Supplementing

Dongzhimen Hospital of Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Aged 18-60 years old;
•(2) Clinically diagnosed with Type 2 diabetes mellitus with a course of less than 8 years. Fasting blood glucose < 7 mmol/L and HbA1c < 7% after drug intervention.
•(3) Presently receiving Western medicine treatment (with unlimited varieties and methods of medication).
•(4) The C-peptide levels of T2DM patients receiving insulin treatment should be greater than or equal to 0.2 nmol/L (0.6 ng/mL);
•(5) BMI < 25 kg/m2;
•(6) Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg in patients with hypertension;
•(7) Being able to follow the treatment, examination and follow-up plan;
•(8) Fully understand and voluntarily sign the informed consent.

•(1) Abnormal liver and kidney functions.
•(2) Alcoholism, malignant tumors, epilepsy or mental disorders;
•(3) Diabetic complications;
•(4) Arrhythmia, cardiopulmonary disfunction or previous stent surgery;
•(5) With a pacemaker, hearing aid or other electronic or metal components;
•(6) Severe infections, infectious diseases and severe skin lesions;
•(7) Pregnant women, pregnancy preparation or lactating women;
•(8) Weight-loss surgery or gastrointestinal surgery;
•(9) Severe pathological changes of gallbladder, thyroid, kidney and other tissues or organs after operation;
•(10) Peptic ulcer;
•(11) Participating in other clinical studies;
•(12) Other reasons that can not cooperate with the study.

发起方

Dongzhimen Hospital of Beijing University of Chinese Medicine